Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality

References

• English RS. A hypothetical pathogenesis model for androgenic alopecia: Clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses 2018;111:73–81.
   PubMed Web of Science ®Google Scholar
• Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine 2017;57(1):9–17.
   PubMed Web of Science ®Google Scholar
• Blume-Peytavi U, Blumeyer A, Tosti A, et al., the European Consensus Group. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol. 2011;164(1):5–15.
   PubMed Web of Science ®Google Scholar
• Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version. J Eur Acad Dermatol Venereol. 2018;32(1):11–22.
   PubMed Web of Science ®Google Scholar
• Tanaka H. Length of hair affects P1 and N170 latencies for perception of women’s faces. Percept Mot Skills 2018;125(6):1011–1028.
   PubMed Web of Science ®Google Scholar
• Cash TF, C TF, Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141:398–405.
   PubMed Web of Science ®Google Scholar
• Girman CJ, Hartmaier S, Roberts J, et al. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med. 1999;8(8):1091–1095.
   PubMedGoogle Scholar
• Rossi A, Anzalone A, Fortuna MC, et al. Multi-therapies in androgenetic alopecia: review and clinical experiences. Dermatol Ther. 2016;29(6):424–432.
   PubMed Web of Science ®Google Scholar
• Gubelin Harcha W, Barboza Martínez J, Tsai T-FT-F, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489–498.e3.
   PubMed Web of Science ®Google Scholar
• Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014–1023.
   PubMed Web of Science ®Google Scholar
• Bayat M, Yazdanpanah MJ, Hamidi Alamdari D, et al. The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia. J Cosmet Dermatol. 2019;18(6):1624–1628.
   PubMed Web of Science ®Google Scholar
• Li T, Puhan MA, Vedula SS, et al., The Ad Hoc Network Meta-analysis Methods Meeting Working Group. Network meta-analysis-highly attractive but more methodological research is needed. BMC Med. 2011;9(1):2–5.
   PubMedGoogle Scholar
• Gupta AK, Mays RR, Dotzert MS, et al. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(12):2112–2125.
   PubMed Web of Science ®Google Scholar
• Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–784.
   PubMed Web of Science ®Google Scholar
• NCSS 2019 Statistical Software. NCSS 2019 statistical software. Kaysville, Utah; 2019. Available from: ncss.com/software/ncss.
   Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14. DOI:https://doi.org/10.1186/1471-2288-14-135
   Google Scholar
• Higgins J, Green S, editors. The Cochrane Collaboration Version 5.1.0. Obtaining standard deviations from standard errors and confidence intervals for group means [Internet]. 2011. Available from: https://handbook-5-1.cochrane.org/chapter_7/7_7_3_2_obtaining_standard_deviations_from_standard_errors_and.htm.
   Google Scholar
• Rohatgi A. WebPlotDigitizer [Internet]. San Francisco, CA: WebPlotDigitizer; 2019. Available from: https://automeris.io/WebPlotDigitizer.
   Google Scholar
• The Cochrane Collaboration. Review manager (RevMan). Copenhagen, Denmark: The Nordic Cochrane Centre; 2014.
   Google Scholar
• Higgins J, Altman D, Sterne J, editors. The cochrane collaboration version 5.1.0. Chapter 8: Assessing risk of bias in included studies [Internet]. 2011. Available from: https://handbook-5-1.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.htm.
   Google Scholar
• Higgins J, Green S. Cochrane handbook for systematic reviews of interventions [Internet]. 2011. Available from: http://handbook-5-1.cochrane.org/.
   Google Scholar
• GRADEpro GDT. GRADEpro guideline development tool [software] [Internet]. Ontario, Canada: Evidence Prime Inc., McMaster University; 2015. Available from: gradepro.org.
   Google Scholar
• Salanti G, Ades AE, Ioannidis J. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163–171.
   PubMed Web of Science ®Google Scholar
• Fan S, Cheng Y-P, Lee M-Y, et al. Efficacy and safety of a low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind. Self-comparison, sham device-controlled trial. Dermatol Surg. 2018;44(11):1411–1420.
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci. 2019;34(6):1107–1114.
   PubMed Web of Science ®Google Scholar
• Barikbin B, Khodamrdi Z, Kholoosi L, et al. Comparison of the effects of 665 nm low level diode Laser Hat versus and a combination of 665 nm and 808 nm low level diode laser scanner of hair growth in androgenic alopecia. J Cosmet Laser Ther. 2017. DOI:https://doi.org/10.1080/14764172.2017.1326609
   Google Scholar
• Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg. 2016;42:491–497.
   PubMed Web of Science ®Google Scholar
• Kim H, Choi JW, Kim JY, et al. Low-level light therapy for androgenetic alopecia: A 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013;39:1177–1183.
   PubMed Web of Science ®Google Scholar
• Dicle Ö, Bilgic Temel A, Gülkesen KH. Platelet-rich plasma injections in the treatment of male androgenetic alopecia: a randomized placebo-controlled crossover study. J Cosmet Dermatol. 2019. DOI:https://doi.org/10.1111/jocd.13146
   Google Scholar
• Gentile P, Garcovich S, Bielli A, et al. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med. 2015;4(11):1317–1323.
   PubMed Web of Science ®Google Scholar
• Hillmann K, Garcia Bartels N, Kottner J, et al. A single-centre, randomized, double-blind, placebo-controlled clinical trial to investigate the efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men. Skin Pharmacol Physiol. 2015;28(5):236–244.
   PubMed Web of Science ®Google Scholar
• Cervelli V, Garcovich S, Bielli A, et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int. 2014;2014:1–9.
   Web of Science ®Google Scholar
• Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–127.
   PubMed Web of Science ®Google Scholar
• Lanzafame RJ, Blanche RR, Bodian AB, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers Surg Med. 2013;45(8):487–495.
   PubMed Web of Science ®Google Scholar
• Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252–258.
   PubMed Web of Science ®Google Scholar
• Leavitt M, Charles G, Heyman E, et al. HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283–292.
   PubMed Web of Science ®Google Scholar
• Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767–774.
   PubMed Web of Science ®Google Scholar
• Prasad H, Khanna N, Pandhi R. A randomized double blind study of the effect of finasteride on hair growth in male patients of androgenetic alopecia. Indian J Dermatol. 2005;50:139–145.
   Google Scholar
• Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377–385.
   PubMed Web of Science ®Google Scholar
• Price VH, Menefee E, Sanchez M, et al. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily. J Am Acad Dermatol. 2002;46(4):517–523.
   PubMed Web of Science ®Google Scholar
• Stough DB, Rao NA, Kaufman KD, et al. Finasteride improves male pattern hair loss in a randomized study in identical twins. Eur J Dermatol. 2002;12:32–37.
   PubMed Web of Science ®Google Scholar
• Van Neste D, Fuh V, Sanchez-Pedreno P, et al. Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol. 2000;143(4):804–810.
   PubMed Web of Science ®Google Scholar
• Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40(6):930–937.
   PubMed Web of Science ®Google Scholar
• Roberts JL, Fiedler V, Imperato-McGinley J, et al. Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41(4):555–563.
   PubMed Web of Science ®Google Scholar
• Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride male pattern hair loss study group. J Am Acad Dermatol. 1998;39(4):578–589.
   PubMed Web of Science ®Google Scholar
• Rushton DH, Unger WP, Cotterill PC, et al. Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness. Clin Exp Dermatol. 1989;14(1):40–46.
   PubMed Web of Science ®Google Scholar
• Anderson CD, the Scandinavian and Middle-Eastern Topical Minoxidil Study Group. Topical minoxidil in androgenetic alopecia scandinavian and middle east experience. Int J Dermatol. 1988;27(s6):447–451.
   Google Scholar
• Civatte J, the European Topical Minoxidil Study Group. Topical 2% minoxidil solution in male pattern alopecia. The initial european experience. Int J Dermatol. 1988;27(s6):424–429.
   Google Scholar
• Dutrée‐Meulenberg R, Nieboer C, Koedijk FHJ, et al. Treatment of male pattern alopecia using topical minoxidil in The Netherlands. Int J Dermatol. 1988;27(s6):435–440.
   Google Scholar
• Petzoldt D, the German Topical Minoxidil Study Group. The German double‐blind placebo‐controlled evaluation of topical minoxidil solution in the treatment of early male pattern baldness. Int J Dermatol. 1988;27(s6):430–434.
   Google Scholar
• Piepkorn MW, Weidner M, P MW, et al. Comparable efficacy of 2% minoxidil gel and solution formulations in the treatment of male pattern alopecia. J Am Acad Dermatol. 1988;18(5):1059–1062.
   PubMed Web of Science ®Google Scholar
• Koperski JA, Orenberg EK, Wilkinson DI, et al. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Arch Dermatol. 1987;123(11):1483–1487.
   PubMedGoogle Scholar
• Shupack JL, Kassimir JJ, Thirumoorthy T, et al. Dose-response study of topical minoxidil in male pattern alopecia. J Am Acad Dermatol. 1987;16(3):673–676.
   PubMed Web of Science ®Google Scholar
• Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol. 1986;15(1):30–37.
   PubMed Web of Science ®Google Scholar
• Friedman S, Schnoor P. Novel approach to treating androgenetic alopecia in females with photobiomodulation (low-level laser therapy). Dermatol Surg. 2017;43:856–867.
   PubMed Web of Science ®Google Scholar
• Bergfeld W, Washenik K, Callender V, et al. A phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss. J Drugs Dermatol. 2016;15:874–881.
   PubMed Web of Science ®Google Scholar
• Blume-Peytavi U, Shapiro J, Messenger AG, et al. Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study. J Drugs Dermatol. 2016;15:883–889.
   PubMed Web of Science ®Google Scholar
• Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541–553.
   PubMed Web of Science ®Google Scholar
• DeVillez RL, Jacobs JP, Szpunar CA, et al. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol. 1994;130(3):303–307.
   PubMedGoogle Scholar
• Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol. 1993;32(10):758–762.
   PubMed Web of Science ®Google Scholar
• Whiting DA, Jacobson C, W DA, et al. Treatment of female androgenetic alopecia with minoxidil 2%. Int J Dermatol. 1992;31(11):800–804.
   PubMed Web of Science ®Google Scholar
• Price VH, Menefee E. Quantitative estimation of hair growth I. Androgenetic alopecia in women: Effect of minoxidil. J Invest Dermatol. 1990;95(6):683–687.
   PubMed Web of Science ®Google Scholar
• Tonin FS, Rotta I, Mendes AM, et al. Network meta-analysis: a technique to gather evidence from direct and indirect comparisons. Pharm Pract. (Granada) 2017;15. DOI:https://doi.org/10.18549/PharmPract.2017.01.943
   Google Scholar
• Kranz D, Nadarevic L, Erdfelder E. Bald and bad? Exp Psychol. 2019;66:331–345.
   PubMed Web of Science ®Google Scholar
• Kanti V, Messenger A, Dobos G, et al. Evidence based (s3) guidelines for the treatment of androgenetic alopecia in women and in men. J Eur Acad Dermatol Venereol. 2017. DOI:https://doi.org/10.1111/jdv.14624
   Google Scholar
• Starace M, Alessandrini A, D'Acunto C, et al. Platelet-rich plasma on female androgenetic alopecia: tested on 10 patients. J Cosmet Dermatol. 2019;18(1):59–64.
   PubMed Web of Science ®Google Scholar